169 related articles for article (PubMed ID: 18789593)
1. Effects of three different topical antibacterial dressings on Acinetobacter baumannii-contaminated full-thickness burns in rats.
Uygur F; Oncül O; Evinç R; Diktas H; Acar A; Ulkür E
Burns; 2009 Mar; 35(2):270-3. PubMed ID: 18789593
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the antibacterial effect of silver sulfadiazine 1%, mupirocin 2%, Acticoat and octenidine dihydrochloride in a full-thickness rat burn model contaminated with multi drug resistant Acinetobacter baumannii.
Selçuk CT; Durgun M; Ozalp B; Tekin A; Tekin R; Akçay C; Alabalık U
Burns; 2012 Dec; 38(8):1204-9. PubMed ID: 22688192
[TBL] [Abstract][Full Text] [Related]
3. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and fusidic acid 2% (Fucidin) for topical antibacterial effect in methicillin-resistant Staphylococci-contaminated, full-skin thickness rat burn wounds.
Ulkür E; Oncul O; Karagoz H; Yeniz E; Celiköz B
Burns; 2005 Nov; 31(7):874-7. PubMed ID: 16011879
[TBL] [Abstract][Full Text] [Related]
4. Comparison of silver-coated dressing (Acticoat), chlorhexidine acetate 0.5% (Bactigrass), and silver sulfadiazine 1% (Silverdin) for topical antibacterial effect in Pseudomonas aeruginosa-contaminated, full-skin thickness burn wounds in rats.
Ulkür E; Oncül O; Karagöz H; Celiköz B; Cavuşlu S
J Burn Care Rehabil; 2005; 26(5):430-3. PubMed ID: 16151289
[TBL] [Abstract][Full Text] [Related]
5. Comparison of silver-coated dressing (Acticoat®), chlorhexidine acetate 0.5% (Bactigrass®) and nystatin for topical antifungal effect in Candida albicans-contaminated, full-skin-thickness rat burn wounds.
Acar A; Uygur F; Diktaş H; Evinç R; Ulkür E; Oncül O; Görenek L
Burns; 2011 Aug; 37(5):882-5. PubMed ID: 21354707
[TBL] [Abstract][Full Text] [Related]
6. Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds.
Muangman P; Chuntrasakul C; Silthram S; Suvanchote S; Benjathanung R; Kittidacha S; Rueksomtawin S
J Med Assoc Thai; 2006 Jul; 89(7):953-8. PubMed ID: 16881426
[TBL] [Abstract][Full Text] [Related]
7. [Effects of topical agents for burns on Acinetobacter baumannii within biofilm].
Huang XQ; Xiang J; Song F; Huan JN
Zhonghua Shao Shang Za Zhi; 2012 Apr; 28(2):106-10. PubMed ID: 22781321
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial dressings: Comparison of the ability of a panel of dressings to prevent biofilm formation by key burn wound pathogens.
Halstead FD; Rauf M; Bamford A; Wearn CM; Bishop JRB; Burt R; Fraise AP; Moiemen NS; Oppenheim BA; Webber MA
Burns; 2015 Dec; 41(8):1683-1694. PubMed ID: 26188884
[TBL] [Abstract][Full Text] [Related]
9. Assessment of the effectiveness of silver-coated dressing, chlorhexidine acetate (0.5%), citric acid (3%), and silver sulfadiazine (1%) for topical antibacterial effects against the multi-drug resistant Pseudomonas aeruginosa infecting full-skin thickness burn wounds on rats.
Yabanoglu H; Basaran O; Aydogan C; Azap OK; Karakayali F; Moray G
Int Surg; 2013; 98(4):416-23. PubMed ID: 24229034
[TBL] [Abstract][Full Text] [Related]
10. A silver coated dressing reduces the incidence of early burn wound cellulitis and associated costs of inpatient treatment: comparative patient care audits.
Fong J; Wood F; Fowler B
Burns; 2005 Aug; 31(5):562-7. PubMed ID: 15993301
[TBL] [Abstract][Full Text] [Related]
11. Comparison of standard and chlorhexidine-derivative topical antibacterial agents on the infected burned rat wound.
Snelling CF; Roberts FJ; Germann E; Gillespie K; Coderre S; Henry D
Burns Incl Therm Inj; 1988 Apr; 14(2):91-100. PubMed ID: 3134114
[TBL] [Abstract][Full Text] [Related]
12. A silver-coated antimicrobial barrier dressing used postoperatively on meshed autografts: a dressing comparison study.
Silver GM; Robertson SW; Halerz MM; Conrad P; Supple KG; Gamelli RL
J Burn Care Res; 2007; 28(5):715-9. PubMed ID: 17667837
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice.
Supp AP; Neely AN; Supp DM; Warden GD; Boyce ST
J Burn Care Rehabil; 2005; 26(3):238-46. PubMed ID: 15879745
[TBL] [Abstract][Full Text] [Related]
14. A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis.
Huang Y; Li X; Liao Z; Zhang G; Liu Q; Tang J; Peng Y; Liu X; Luo Q
Burns; 2007 Mar; 33(2):161-6. PubMed ID: 17175106
[TBL] [Abstract][Full Text] [Related]
15. Use of Acticoat dressings in burns: what is the evidence?
Khundkar R; Malic C; Burge T
Burns; 2010 Sep; 36(6):751-8. PubMed ID: 20346592
[TBL] [Abstract][Full Text] [Related]
16. Antibacterial effect of dressings containing multivalent silver ion carried by zirconium phosphate on experimental rat burn wounds.
Luo G; Tang J; He W; Wu J; Ma B; Wang X; Chen X; Yi S; Zhang X; Li X; Fitzgerald M
Wound Repair Regen; 2008; 16(6):800-4. PubMed ID: 19128251
[TBL] [Abstract][Full Text] [Related]
17. Treatment of paediatric burns with a nanocrystalline silver dressing compared with standard wound care in a burns unit: a cost analysis.
Cox SG; Cullingworth L; Rode H
S Afr Med J; 2011 Sep; 101(10):728-31. PubMed ID: 22272852
[TBL] [Abstract][Full Text] [Related]
18. A prospective, randomized trial of Acticoat versus silver sulfadiazine in the treatment of partial-thickness burns: which method is less painful?
Varas RP; O'Keeffe T; Namias N; Pizano LR; Quintana OD; Herrero Tellachea M; Rashid Q; Ward CG
J Burn Care Rehabil; 2005; 26(4):344-7. PubMed ID: 16006842
[TBL] [Abstract][Full Text] [Related]
19. [Multi-center clinical study of acticoat (nanocrystalline silver dressing) for the management of residual burn wounds].
Li XL; Huang YS; Peng YZ; Liao ZJ; Zhang GA; Liu Q; Tang J; Liu XS; Luo QZ
Zhonghua Shao Shang Za Zhi; 2006 Feb; 22(1):15-8. PubMed ID: 16680954
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of monotherapy and combined antibiotic therapy for carbapenem-resistant Acinetobacter baumannii pneumonia in an immunosuppressed mouse model.
Song JY; Cheong HJ; Lee J; Sung AK; Kim WJ
Int J Antimicrob Agents; 2009 Jan; 33(1):33-9. PubMed ID: 18835761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
